Drugging the Undruggable
Add to My Pictures
|Title:||Drugging the Undruggable|
A clinical trial showed that sotorasib controlled non-small cell lung cancer in about 80% of patients with the G12C KRAS mutation.
This image is part of the NCI Annual Plan and Budget Proposal FY 2024 collection.
See also www.cancer.gov/research/annual-plan.
|Type:||Color, Illustration (JPEG format)|
|Source:||Nation Cancer Institute (NCI)|
|Creator:||Nation Cancer Institute (NCI)|
|Date Created:||August 18, 2022|
|Date Added:||September 14, 2022|
|Reuse Restrictions:||None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above.|